SOX1 Antibody, IgG by Immunoblot, CSF
Also known as: SOX1 CSF
Use
SOX1 antibody is primarily used for detecting Lambert-Eaton myasthenic syndrome (LEMS) and paraneoplastic cerebellar degeneration (PCD). It is associated with occult tumors, recurrence of tumors, or the presence of second tumors, particularly with small cell lung cancer. A negative result does not rule out LEMS or other paraneoplastic neurological syndromes.
Special Instructions
Not provided.
Limitations
This qualitative immunoblot test does not provide a quantitative measure of the SOX1 antibody level. A negative result in this test does not completely exclude the diagnosis of LEMS or other paraneoplastic neurological syndromes. Potential interferences include contaminated, heat-inactivated, hemolyzed, or lipemic specimens, which can be rejected.
New York Approved
Methodology
Immunoassay (Western Blot)
Biomarkers
SOX1 Antibody
Protein
LOINC Codes
- 94383-7 - Glial nuc type 1 IgG CSF Ql Line blot
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
1 mL
Minimum Volume
0.60 mL
Container
ARUP Standard Transport Tube
Storage Instructions
Refrigerated.
Causes for Rejection
Contaminated, heat-inactivated, hemolyzed, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 month |
Other tests from different labs that may be relevant